AR071968A1 - Uso de un oligosacarido en el tratamiento de la inflamacion intestinal - Google Patents

Uso de un oligosacarido en el tratamiento de la inflamacion intestinal

Info

Publication number
AR071968A1
AR071968A1 ARP090101953A ARP090101953A AR071968A1 AR 071968 A1 AR071968 A1 AR 071968A1 AR P090101953 A ARP090101953 A AR P090101953A AR P090101953 A ARP090101953 A AR P090101953A AR 071968 A1 AR071968 A1 AR 071968A1
Authority
AR
Argentina
Prior art keywords
gal
treatment
glc
inflammation
oligosacarido
Prior art date
Application number
ARP090101953A
Other languages
English (en)
Inventor
Geogios Tzortzis
Jelena Vulevic
Original Assignee
Clasado Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clasado Inc filed Critical Clasado Inc
Publication of AR071968A1 publication Critical patent/AR071968A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente se refiere al uso de un oligosac rido, en particular una composicion de oligosac rido no digerible, en la prevencion o tratamiento de inflamacion, en particular inflamacion intestinal. Reivindicacion 4: La composicion de conformidad con la reivindicacion 3, caracterizada porque la mezcla de galactooligosac ridos comprende un disac rido Gal-Gal, un trisac rido Gal-Gal-Glc, un tetrasac rido Gal-Gal-Gal-Glc y un pentasac rido Gal-Gal-Gal-Gal-Glc. Reivindicacion 8: La composicion de conformidad con la reivindicacion 6, para uso al prevenir o reducir la inflamacion inducida por TNF-alfa (Factor de necrosis del tejido) en celulas de epitelio intestinal.
ARP090101953A 2008-05-30 2009-05-29 Uso de un oligosacarido en el tratamiento de la inflamacion intestinal AR071968A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0809921.0A GB0809921D0 (en) 2008-05-30 2008-05-30 Product and process therefor

Publications (1)

Publication Number Publication Date
AR071968A1 true AR071968A1 (es) 2010-07-28

Family

ID=39637923

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090101953A AR071968A1 (es) 2008-05-30 2009-05-29 Uso de un oligosacarido en el tratamiento de la inflamacion intestinal

Country Status (9)

Country Link
US (1) US20110082102A1 (es)
EP (1) EP2288356A1 (es)
CN (1) CN102046181A (es)
AR (1) AR071968A1 (es)
AU (1) AU2009286558A1 (es)
CA (1) CA2724766A1 (es)
GB (1) GB0809921D0 (es)
TW (1) TW201000108A (es)
WO (1) WO2010023422A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525857D0 (en) * 2005-12-20 2006-02-01 Product and process
GB0606112D0 (en) 2006-03-28 2006-05-03 Product and process
GB0906983D0 (en) * 2009-04-23 2009-06-03 Clasado Inc Novel use
MX2011012603A (es) 2009-05-27 2012-06-01 Clasado Inc Metodo para prevenir la diarrea.
WO2012092156A1 (en) 2010-12-31 2012-07-05 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
BR112013016606A2 (pt) 2010-12-31 2016-09-27 Abbott Lab processos para redução de incidência de tensão oxidante usando oligossacarídeos de leite humano, vitamina c e agentes antiflamatórios
GB2492559B (en) 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
ES2657744T3 (es) 2011-07-22 2018-03-06 Abbott Laboratories Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal
US10639319B2 (en) 2011-08-29 2020-05-05 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US9545415B2 (en) * 2012-01-06 2017-01-17 Skyview Enterprise Ltd. Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation
US11179430B2 (en) 2012-06-08 2021-11-23 Finzelberg Gmbh & Co. Kg Extracts from mother-of-thyme and the use i'hereof
GB201305708D0 (en) * 2013-03-28 2013-05-15 Clasado Inc Novel use
WO2015007326A1 (en) * 2013-07-18 2015-01-22 Institut D'investigació Biomèdica De Bellvitge (Idibell) Agents comprising a terminal alpha-galactosyl moiety for use in prevention and/or treatment of inflammatory diseases
US10222370B2 (en) 2014-04-07 2019-03-05 Rush University Medical Center Screening assay for choice of prebiotic to prevent/treat gastrointestinal and systemic diseases
BR112021022447A2 (pt) 2019-05-15 2021-12-28 Nutricia Nv Métodos para aumentar a função da barreira intestinal e/ou para a prevenção e/ou o tratamento de ruptura da barreira intestinal, método para o tratamento, a prevenção e/ou o alívio de uma condição associado à exposição a toxinas, fórmula infantil, fórmula de seguimento ou fórmula para criança de primeira infância, trissacarídeos, composições nutricionais, uso do trissacarídeo e usos de uma composição nutricional
US20220110985A1 (en) * 2019-06-04 2022-04-14 N.V. Nutricia Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose
PT3883393T (pt) * 2019-06-04 2022-12-07 Nutricia Nv Composição nutricional compreendendo 2'fucosilactose e butirato dietético
US20240277739A1 (en) * 2021-07-01 2024-08-22 N.V. Nutricia Nutritonal compositions for gut barrier function

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435389A (en) * 1980-07-07 1984-03-06 Kabushiki Kaisha Yakult Honsha Composition for promoting growth of bifidobacteria
JP2711095B2 (ja) * 1986-09-27 1998-02-10 ユニチカ株式会社 ビフイドバクテリウム菌の増殖促進剤の製造法
JP2518663B2 (ja) * 1987-12-24 1996-07-24 株式会社ヤクルト本社 ガラクトオリゴ糖含有加工乳の製造法
US5149640A (en) * 1988-12-22 1992-09-22 Ajinomoto Co., Inc. Method for producing galactose transfer products
DE60126269T2 (de) * 2000-05-26 2007-06-21 Arla Foods Amba Isolierte beta-galactosidase von bifidobacterium
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
GB2412380B (en) * 2003-06-30 2005-11-09 Clasado Inc Novel galactooligosaccharide composition and the preparation thereof

Also Published As

Publication number Publication date
AU2009286558A1 (en) 2010-03-04
US20110082102A1 (en) 2011-04-07
CN102046181A (zh) 2011-05-04
GB0809921D0 (en) 2008-07-09
EP2288356A1 (en) 2011-03-02
WO2010023422A8 (en) 2010-12-02
TW201000108A (en) 2010-01-01
CA2724766A1 (en) 2010-03-04
WO2010023422A1 (en) 2010-03-04

Similar Documents

Publication Publication Date Title
AR071968A1 (es) Uso de un oligosacarido en el tratamiento de la inflamacion intestinal
ECSP11011459A (es) Composiciones sublinguales de dexmedetomidina y métodos de uso de ellas
TN2011000416A1 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
CO6531427A2 (es) Composiciones de corticosteriodes administradas oralmente
GB2465677B (en) Non-systemic delivery of satiogens for use in the treatment of obesity and/or diabetes
EA021554B9 (ru) Органические соединения и их применение для лечения hcv инфекции
NI201100043A (es) Derivados de dioxa - biciclo [ 3. 2. 1 ] octano - 2, 3, 4 - triol.
EA201001698A1 (ru) Инсулиновые композиции сверхбыстрого действия
CL2008001373A1 (es) Compuestos derivados de fenilamino-benceno sustituidos; metodo de preparacion; composicion farmaceutica; kit farmceuticos; y uso de dichos compuestos en el tratamiento del cancer.
MX2013003034A (es) Lactamas piperidinilo-substituidas como moduladores de gpr119.
BR112014015940A2 (pt) composição de novo fármaco de carboidrato para tratamento de doenças humanas
CO6640246A2 (es) Forma cristalina del inhibidor sglt2 bencilbenceno
EA201690964A1 (ru) Композиции и способы для уменьшения серьезных неблагоприятных сердечно-сосудистых явлений
MX2012005014A (es) Formulaciones de sulfoxido de dimetilo (dmso) y metilsulfonilmetano (msm) para tratar osteoartritis.
CL2008003546A1 (es) Compuestos derivados de piridina; procedimiento de preparacion; composicion farmaceutica de dichos compuestos; y uso en el tratamiento y/o profilaxis de la diabetes mellitus tipo i y/o tipo ii.
CL2011001943A1 (es) Terapia antibiotica para tartar o prevenir el sindrome del intestino irritable post- infeccioso.
NZ592049A (en) Compositions and methods for the treatment of bowel diseases with granulated mesalamine
UY33153A (es) Formulación tópica oftálmica de péptidos
UA109879C2 (uk) Похідні нітрилу, їх застосування у фармацевтичних цілях і в композиції
WO2010151004A3 (ko) 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물
WO2011151786A3 (en) Injectable formulation of a reverse transcriptase inhibitor for the treatment cancer
WO2010086617A3 (en) Phosphoantigens for the treatment of burkholderia infections
AR072066A1 (es) Uso de composicion que comprende oligosacaridos no digeribles
CL2010001589A1 (es) Compuestos derivados de 3-ciano-pirrolidin-fenil-oxazolidinonas; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas.
CL2009001005A1 (es) Compuestos derivados de butirato de trimetilamonio, inhibidores de cpt2; proceso de preparacion; composicion farmaceutica que los comprende; y uso en el tratamiento o prevencion de enfermedades tales como hiperglucemia, diabetes, hipertension, entre otras patologias.

Legal Events

Date Code Title Description
FB Suspension of granting procedure